The auto-injector market is projected to grow at a CAGR of 8.2% from 2023 to 2033, underscoring the rising demand for these ...
GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...
Mouse models demonstrated significant prevention and suppression of MS symptoms with fexagratinib, highlighting its ...
GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...
Application Areas: Medical nutrition products are being widely used in oncology, diabetes, gastrointestinal diseases, critical care, and other therapeutic areas. The oncology segment is projected to ...
What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first ...
In CNS disorders, controlled gene expression may address challenges in treating neurological diseases by delivering ...
As of September 30, 2024, Zymeworks has repurchased 1,818,530 shares of the Company's common stock for a cost of $20.6 ...
SLE is a chronic and complex heterogeneous autoimmune disease in which the immune system dysfunctions and inappropriately ...
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.